What is Needham's price target for SAGE?

Needham's latest stated price target for Sage Therapeutics Inc. (SAGE) is $85, from its action on Jan 6, 2022.

What is Needham's rating on SAGE?

Needham rates SAGE Hold, a neutral rating, as of Aug 8, 2023.

When did Needham last change its view on SAGE?

On Aug 8, 2023, Needham downgrades to Hold from Buy.

Needham SAGE price target and rating history

Sage Therapeutics Inc. (SAGE) · Health Care

Needham rates Sage Therapeutics Inc. (SAGE) Hold with a $85 price target, as of its latest action on Aug 8, 2023. It has published 4 rating actions on SAGE since September 2021, including 0 upgrades and 1 downgrade.

Current rating: Hold
Price target: $85
Median target, all firms: Too few
Actions on SAGE: 4

Needham price target on SAGE

Needham price target on SAGE, each point a stated target, September 2021 to January 2022.

Every Needham rating on SAGE

Aug 8, 2023
DowngradeNeedham downgrades to Hold from Buy
Jan 6, 2022
ReiterateNeedham raises its price target to $85 from $79, keeps Buy
Oct 20, 2021
ReiterateNeedham cuts its price target to $79 from $84, keeps Buy
Sep 23, 2021
InitiateNeedham starts coverage at Buy, price target $84

Questions about Needham and SAGE

What is Needham's price target for SAGE?: Needham's latest stated price target for Sage Therapeutics Inc. (SAGE) is $85, from its action on Jan 6, 2022.
What is Needham's rating on SAGE?: Needham rates SAGE Hold, a neutral rating, as of Aug 8, 2023.
When did Needham last change its view on SAGE?: On Aug 8, 2023, Needham downgrades to Hold from Buy.

More SAGE rating histories

All Needham ratings SAGE news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.